Perfusion Pressure Is a Critical Determinant of the Intratumoral Extravasation of Oncolytic Viruses-Reference-Cited by-同舟云学术

Perfusion Pressure Is a Critical Determinant of the Intratumoral Extravasation of Oncolytic Viruses

Published:2016-02 Issue:2 Volume:24 Page:306-317
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Miller Amber,Nace Rebecca,Ayala-Breton C Camilo,Steele Michael,Bailey Kent,Peng Kah Whye,Russell Stephen J

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference61 articles.

1. Recent clinical experience with oncolytic viruses;Donnelly;Curr Pharm Biotechnol,2012

2. Oncolytic virotherapy;Russell;Nat Biotechnol,2012

3. Viruses as anticancer drugs;Russell;Trends Pharmacol Sci,2007

4. Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded;Cattaneo;Nat Rev Microbiol,2008

5. Heterogeneous delivery is a barrier to the translational advancement of oncolytic virotherapy for treating solid tumors;Miller;Virus Adapt Treat,2014

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breaking Barriers: Unleashing the Potential of ABO Blood Group Antigen Therapy in the Battle against Solid Tumors;Blood Groups - New Perspectives [Working Title];2023-12-07

2. Strategies to improve the EPR effect: A mechanistic perspective and clinical translation;Journal of Controlled Release;2022-05

3. Clinical Activity of Single Dose Systemic Oncolytic VSV Virotherapy in Patients with Relapsed Refractory T-Cell Lymphoma;Blood Advances;2022-02-17

4. Replication and Spread of Oncolytic Herpes Simplex Virus in Solid Tumors;Viruses;2022-01-10

5. Multiple Treatment Cycles of Neural Stem Cell Delivered Oncolytic Adenovirus for the Treatment of Glioblastoma;Cancers;2021-12-16